APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Retinal Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Retinal Drugs Industry Growth and Trends Forecast to 2032

Report ID 174032600120 December 202598 pages

Choose your research edition.

Industry ResearchRetinal Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Retinal Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Retinal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Retinal Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Retinal Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Retinal Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Retinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Retinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Retinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Retinal Drugs include F. Hoffmann-La Roche, Regeneron, ThromboGenics, Bayer, Merck, Novartis, Teva Pharmaceutical and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Retinal Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Retinal Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Retinal Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Retinal Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Retinal Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Retinal Drugs Market by Company

F. Hoffmann-La Roche

Regeneron

ThromboGenics

Bayer

Merck

Novartis

Teva Pharmaceutical

Takeda

Retinal Drugs Segment by Type

Diabetic Retinopathy

DME

RVO

Wet AMD

Mcnv

Retinal Drugs Segment by Application

Hospitial

Clinicl

Others

Retinal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retinal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Retinal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retinal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Retinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Retinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diabetic Retinopathy Table 2. Major Company of DME Table 3. Major Company of RVO Table 4. Major Company of Wet AMD Table 5. Major Company of Mcnv Table 6. Global Retinal Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Retinal Drugs Sales by Type (2021-2026) & (k units) Table 8. Global Retinal Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Retinal Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Retinal Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Retinal Drugs Price by Type (2021-2026) & (US$/unit) Table 12. Global Retinal Drugs Sales by Type (2027-2032) & (k units) Table 13. Global Retinal Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Retinal Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Retinal Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Retinal Drugs Price by Type (2027-2032) & (US$/unit) Table 17. North America Retinal Drugs Sales by Type (2021-2026) & (k units) Table 18. North America Retinal Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Retinal Drugs Sales by Type (2021-2026) & (k units) Table 20. Europe Retinal Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Retinal Drugs Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Retinal Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Retinal Drugs Sales by Type (2021-2026) & (k units) Table 24. Latin America Retinal Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Retinal Drugs Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Retinal Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Retinal Drugs Industry Trends Table 28. Retinal Drugs Industry Drivers Table 29. Retinal Drugs Industry Opportunities and Challenges Table 30. Retinal Drugs Industry Restraints Table 31. Global Retinal Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Retinal Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Retinal Drugs Sales by Company (2021-2026) & (k units) Table 34. Global Retinal Drugs Sales Share by Company (2021-2026) Table 35. Global Retinal Drugs Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Retinal Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Retinal Drugs Major Company Production Sites and Headquarters Table 38. Global Retinal Drugs Company, Product Type & Application Table 39. Global Retinal Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Retinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Retinal Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Retinal Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Retinal Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Retinal Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Retinal Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Retinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Retinal Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Retinal Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Retinal Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Retinal Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Retinal Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Retinal Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Retinal Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Retinal Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Retinal Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Retinal Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Retinal Drugs Price by Application (2021-2026) & (US$/unit) Table 59. Global Retinal Drugs Sales by Application (2027-2032) & (k units) Table 60. Global Retinal Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Retinal Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Retinal Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Retinal Drugs Price by Application (2027-2032) & (US$/unit) Table 64. North America Retinal Drugs Sales by Application (2021-2026) & (k units) Table 65. North America Retinal Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Retinal Drugs Sales by Application (2021-2026) & (k units) Table 67. Europe Retinal Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Retinal Drugs Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Retinal Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Retinal Drugs Sales by Application (2021-2026) & (k units) Table 71. Latin America Retinal Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Retinal Drugs Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Retinal Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. F. Hoffmann-La Roche Company Information Table 75. F. Hoffmann-La Roche Business Overview Table 76. F. Hoffmann-La Roche Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. F. Hoffmann-La Roche Retinal Drugs Product Portfolio Table 78. F. Hoffmann-La Roche Recent Development Table 79. Regeneron Company Information Table 80. Regeneron Business Overview Table 81. Regeneron Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Regeneron Retinal Drugs Product Portfolio Table 83. Regeneron Recent Development Table 84. ThromboGenics Company Information Table 85. ThromboGenics Business Overview Table 86. ThromboGenics Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. ThromboGenics Retinal Drugs Product Portfolio Table 88. ThromboGenics Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Bayer Retinal Drugs Product Portfolio Table 93. Bayer Recent Development Table 94. Merck Company Information Table 95. Merck Business Overview Table 96. Merck Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Merck Retinal Drugs Product Portfolio Table 98. Merck Recent Development Table 99. Novartis Company Information Table 100. Novartis Business Overview Table 101. Novartis Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Novartis Retinal Drugs Product Portfolio Table 103. Novartis Recent Development Table 104. Teva Pharmaceutical Company Information Table 105. Teva Pharmaceutical Business Overview Table 106. Teva Pharmaceutical Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Teva Pharmaceutical Retinal Drugs Product Portfolio Table 108. Teva Pharmaceutical Recent Development Table 109. Takeda Company Information Table 110. Takeda Business Overview Table 111. Takeda Retinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Takeda Retinal Drugs Product Portfolio Table 113. Takeda Recent Development Table 114. North America Retinal Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. North America Retinal Drugs Sales by Country (2021-2026) & (k units) Table 116. North America Retinal Drugs Sales Market Share by Country (2021-2026) Table 117. North America Retinal Drugs Sales Forecast by Country (2027-2032) & (k units) Table 118. North America Retinal Drugs Sales Market Share Forecast by Country (2027-2032) Table 119. North America Retinal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Retinal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Retinal Drugs Market Share by Country (2021-2026) Table 122. North America Retinal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Retinal Drugs Market Share Forecast by Country (2027-2032) Table 124. Europe Retinal Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Europe Retinal Drugs Sales by Country (2021-2026) & (k units) Table 126. Europe Retinal Drugs Sales Market Share by Country (2021-2026) Table 127. Europe Retinal Drugs Sales Forecast by Country (2027-2032) & (k units) Table 128. Europe Retinal Drugs Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Retinal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Retinal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Retinal Drugs Market Share by Country (2021-2026) Table 132. Europe Retinal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Retinal Drugs Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Retinal Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Retinal Drugs Sales by Country (2021-2026) & (k units) Table 136. Asia-Pacific Retinal Drugs Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Retinal Drugs Sales Forecast by Country (2027-2032) & (k units) Table 138. Asia-Pacific Retinal Drugs Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Retinal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Retinal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Retinal Drugs Market Share by Country (2021-2026) Table 142. Asia-Pacific Retinal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Retinal Drugs Market Share Forecast by Country (2027-2032) Table 144. Latin America Retinal Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Latin America Retinal Drugs Sales by Country (2021-2026) & (k units) Table 146. Latin America Retinal Drugs Sales Market Share by Country (2021-2026) Table 147. Latin America Retinal Drugs Sales Forecast by Country (2027-2032) & (k units) Table 148. Latin America Retinal Drugs Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Retinal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Retinal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Retinal Drugs Market Share by Country (2021-2026) Table 152. Latin America Retinal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Retinal Drugs Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Retinal Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Retinal Drugs Sales by Country (2021-2026) & (k units) Table 156. Middle East and Africa Retinal Drugs Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Retinal Drugs Sales Forecast by Country (2027-2032) & (k units) Table 158. Middle East and Africa Retinal Drugs Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Retinal Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Retinal Drugs Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Retinal Drugs Market Share by Country (2021-2026) Table 162. Middle East and Africa Retinal Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Retinal Drugs Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Retinal Drugs Distributors List Table 167. Retinal Drugs Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Retinal Drugs Image Figure 2. Global Retinal Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Retinal Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Retinal Drugs Sales (2021-2032) & (k units) Figure 5. Diabetic Retinopathy Image Figure 6. Global Diabetic Retinopathy Sales YoY Growth (2021-2032) & (k units) Figure 7. DME Image Figure 8. Global DME Sales YoY Growth (2021-2032) & (k units) Figure 9. RVO Image Figure 10. Global RVO Sales YoY Growth (2021-2032) & (k units) Figure 11. Wet AMD Image Figure 12. Global Wet AMD Sales YoY Growth (2021-2032) & (k units) Figure 13. Mcnv Image Figure 14. Global Mcnv Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Retinal Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Retinal Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Retinal Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Retinal Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Retinal Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Retinal Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Retinal Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Retinal Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Retinal Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Retinal Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Retinal Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Retinal Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Retinal Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospitial Image Figure 30. Global Hospitial Sales YoY Growth (2021-2032) & (k units) Figure 31. Clinicl Image Figure 32. Global Clinicl Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Retinal Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Retinal Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Retinal Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Retinal Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Retinal Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Retinal Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Retinal Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Retinal Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Retinal Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Retinal Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Retinal Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Retinal Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Retinal Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Retinal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Retinal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Retinal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Retinal Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Retinal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Retinal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Retinal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Retinal Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Retinal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Retinal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Retinal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Retinal Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Retinal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Retinal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Retinal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Retinal Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Retinal Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Retinal Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Retinal Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Retinal Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Retinal Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Diabetic Retinopathy
  • DME
  • RVO
  • Wet AMD
  • Mcnv
Applications
  • Hospitial
  • Clinicl
  • Others
Companies covered
  • F. Hoffmann-La Roche
  • Regeneron
  • ThromboGenics
  • Bayer
  • Merck
  • Novartis
  • Teva Pharmaceutical
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Retinal Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Retinal Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Retinal Drugs Market by Type
  6. 1.3.1 Diabetic Retinopathy
  7. 1.3.2 DME
  8. 1.3.3 RVO
  9. 1.3.4 Wet AMD
  10. 1.3.5 Mcnv
  11. 1.4 Global Retinal Drugs Market Size by Type
  12. 1.4.1 Global Retinal Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Retinal Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Retinal Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Retinal Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Retinal Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Retinal Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Retinal Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Retinal Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Retinal Drugs Industry Trends
  2. 2.2 Retinal Drugs Industry Drivers
  3. 2.3 Retinal Drugs Industry Opportunities and Challenges
  4. 2.4 Retinal Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Retinal Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Retinal Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Retinal Drugs Price (2021-2026)
  4. 3.4 Global Retinal Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Retinal Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Retinal Drugs Company, Product Type & Application
  7. 3.7 Global Retinal Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Retinal Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Retinal Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Retinal Drugs Tier 1, Tier 2, and Tier 3
4 Retinal Drugs Regional Status and Outlook
  1. 4.1 Global Retinal Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Retinal Drugs Historic Market Size by Region
  3. 4.2.1 Global Retinal Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Retinal Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Retinal Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Retinal Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Retinal Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Retinal Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Retinal Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Retinal Drugs by Application
  1. 5.1 Retinal Drugs Market by Application
  2. 5.1.1 Hospitial
  3. 5.1.2 Clinicl
  4. 5.1.3 Others
  5. 5.2 Global Retinal Drugs Market Size by Application
  6. 5.2.1 Global Retinal Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Retinal Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Retinal Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Retinal Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Retinal Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Retinal Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Retinal Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Retinal Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 F. Hoffmann-La Roche
  2. 6.1.1 F. Hoffmann-La Roche Company Information
  3. 6.1.2 F. Hoffmann-La Roche Business Overview
  4. 6.1.3 F. Hoffmann-La Roche Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 F. Hoffmann-La Roche Retinal Drugs Product Portfolio
  6. 6.1.5 F. Hoffmann-La Roche Recent Developments
  7. 6.2 Regeneron
  8. 6.2.1 Regeneron Company Information
  9. 6.2.2 Regeneron Business Overview
  10. 6.2.3 Regeneron Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regeneron Retinal Drugs Product Portfolio
  12. 6.2.5 Regeneron Recent Developments
  13. 6.3 ThromboGenics
  14. 6.3.1 ThromboGenics Company Information
  15. 6.3.2 ThromboGenics Business Overview
  16. 6.3.3 ThromboGenics Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ThromboGenics Retinal Drugs Product Portfolio
  18. 6.3.5 ThromboGenics Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Retinal Drugs Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Retinal Drugs Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Retinal Drugs Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Teva Pharmaceutical
  38. 6.7.1 Teva Pharmaceutical Company Information
  39. 6.7.2 Teva Pharmaceutical Business Overview
  40. 6.7.3 Teva Pharmaceutical Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Retinal Drugs Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Recent Developments
  43. 6.8 Takeda
  44. 6.8.1 Takeda Company Information
  45. 6.8.2 Takeda Business Overview
  46. 6.8.3 Takeda Retinal Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takeda Retinal Drugs Product Portfolio
  48. 6.8.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Retinal Drugs Sales by Country
  2. 7.1.1 North America Retinal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Retinal Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Retinal Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Retinal Drugs Market Size by Country
  6. 7.2.1 North America Retinal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Retinal Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Retinal Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Retinal Drugs Sales by Country
  2. 8.1.1 Europe Retinal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Retinal Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Retinal Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Retinal Drugs Market Size by Country
  6. 8.2.1 Europe Retinal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Retinal Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Retinal Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Retinal Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Retinal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Retinal Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Retinal Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Retinal Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Retinal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Retinal Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Retinal Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Retinal Drugs Sales by Country
  2. 10.1.1 South America Retinal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Retinal Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Retinal Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Retinal Drugs Market Size by Country
  6. 10.2.1 South America Retinal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Retinal Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Retinal Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Retinal Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Retinal Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Retinal Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Retinal Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Retinal Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Retinal Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Retinal Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Retinal Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Retinal Drugs Value Chain Analysis
  2. 12.1.1 Retinal Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Retinal Drugs Production Mode & Process
  7. 12.2 Retinal Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Retinal Drugs Distributors
  10. 12.2.3 Retinal Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst